Catalog record · Operations & Efficiency
Stage as of Nov 26, 2025 · historical report, not live reconfirmation.
Randomized operational comparison of ambient note-drafting tools
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Oct 29, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
UCLA randomized 238 physicians to Nabla, DAX or usual documentation. Physicians reviewed/edited generated notes. Nabla's note-time reduction was 9.5% greater than control; DAX's reduction was not statistically significant.
- Reported stage
- Pilot
- Technology
- Other supported technology
- Business function
- Not assessed
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 29, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Completed operational pilot — November 2024 to January 2025; primary institutional report 2025-11-26. Status as of 2025-11-26.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Both products showed potential well-being benefits, while efficiency differed. Clinicians reported occasional significant omissions/pronoun errors and one mild safety event. Thus adoption, ease of use and satisfaction cannot substitute for end-to-end time and material-error measurement. Short trial at one academic system; medical notes and professional interviews have different requirements. No inference to headcount, revenue or client outcomes.
Potential FS application · inferred
Inference: adviser/adjuster interview notes evaluated using randomized deployment and complete note-finalization time. Missing capability: distinguish tool-specific efficiency from subjective workload benefits.
Inference: adviser/adjuster interview notes evaluated using randomized deployment and complete note-finalization time. Missing capability: distinguish tool-specific efficiency from subjective workload benefits.
Original industry: Healthcare. Transfer limits: Short trial at one academic system; medical notes and professional interviews have different requirements. No inference to headcount, revenue or client outcomes.
Source register
- UCLA study finds AI scribes may reduce documentation time and improve physician well-beinguclahealth.org · opens in a new tab
UCLA Health · issuer · full-text · Published 2025-11-26
Research lanes: healthcare_legal_transfer · Batch global-discovery-2026-10-29. Coverage and remaining gaps